Caldwell William S

CIK 00012958291 companyWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001295829

Recent Transactions

46 trades

Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-31−2,655→ 18,595 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$26.37/sh−2,655→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$2.93/sh+2,655→ 10,390 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$2.93/sh+2,655→ 10,390 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-31−2,655→ 18,595 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-03-31$26.37/sh−2,655→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−14,278→ 42,832 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−2,722→ 21,547 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$5.55/sh+2,722→ 10,457 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$8.51/sh+14,278→ 24,735 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$24.29/sh−17,000→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$5.55/sh+2,722→ 10,457 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$8.51/sh+14,278→ 24,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−2,722→ 21,547 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-03$24.29/sh−17,000→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-03−14,278→ 42,832 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$24.27/sh−15,263→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$5.55/sh+15,263→ 22,998 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-30−15,263→ 24,269 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$5.55/sh+15,263→ 22,998 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-30$24.27/sh−15,263→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-30−15,263→ 24,269 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-31$14.54/sh−13,955→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-31$1.75/sh+13,955→ 21,690 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-31$14.54/sh−13,955→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-31−13,955→ 2,100 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-31$1.75/sh+13,955→ 21,690 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-31−13,955→ 2,100 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$14.08/sh−500→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-28−5,900→ 16,055 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-28−500→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$14.50/sh−5,900→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-28−5,900→ 16,055 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$1.75/sh+5,900→ 13,635 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$1.75/sh+500→ 8,235 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-28−500→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$14.50/sh−5,900→ 7,735 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$14.08/sh−500→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$1.75/sh+5,900→ 13,635 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-28$1.75/sh+500→ 8,235 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-27−1,600→ 500 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-27$14.00/sh−1,600→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-27$1.75/sh+1,600→ 9,335 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-27$14.00/sh−1,600→ 7,735 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-08-27$1.75/sh+1,600→ 9,335 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-08-27−1,600→ 500 total

Companies

GYRE THERAPEUTICS, INC.
SVP - Drug Discovery and Dev.
$GYRE

Recent Filings

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101

View on SEC.gov